Kenvue Has Gone Public: Should You Buy the Stock?

Johnson & Johnson (NYSE: JNJ) officially spun off its consumer health business this month, creating the largest U.S. initial public offering since 2021. Kenvue (NYSE: KVUE) began trading as a stand-alone business and gives healthcare investors a new stock to potentially add to their portfolios. Although Kenvue is technically a separate company, Johnson & Johnson will still play a big role in its operations; the healthcare company will own a 90% stake in the business.